Brief: Silexion Therapeutics Corp Unveils Expanded Development Plan For Sil204
28/03/2025 12:34
March 28 (Reuters) - Silexion Therapeutics Corp SLXN.O: SILEXION THERAPEUTICS CORP - UNVEILS EXPANDED DEVELOPMENT PLAN FOR SIL204 - SEC FILING SILEXION THERAPEUTICS CORP - TO CONDUCT ADDITIONAL TOXICOLOGY AND PHARMACODYNAMIC STUDIES IN 2025 Further company coverage: SLXN.O ((Reuters.Briefs@thomsonreuters.com;))